0001104659-15-049016.txt : 20150630
0001104659-15-049016.hdr.sgml : 20150630
20150630184634
ACCESSION NUMBER: 0001104659-15-049016
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150630
FILED AS OF DATE: 20150630
DATE AS OF CHANGE: 20150630
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATABASIS PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001454789
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-349-1971
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: BLDG. 1400E, SUITE B14202
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV Life Sciences Fund V Strategic Partners, L.P.
CENTRAL INDEX KEY: 0001482194
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 15962720
BUSINESS ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-973-2708
MAIL ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV LIFE SCIENCES FUND V LP
CENTRAL INDEX KEY: 0001460732
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 15962721
BUSINESS ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-973-2708
MAIL ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SV Life Sciences Fund V (GP), LP
CENTRAL INDEX KEY: 0001644146
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 15962722
BUSINESS ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SVLSF V, LLC
CENTRAL INDEX KEY: 0001644160
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37467
FILM NUMBER: 15962723
BUSINESS ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
BUSINESS PHONE: 617-367-8100
MAIL ADDRESS:
STREET 1: C/O SV LIFE SCIENCES ADVISERS, LLC
STREET 2: ONE BOSTON PLACE, SUITE 3900
CITY: BOSTON
STATE: MA
ZIP: 02108
4
1
a4.xml
4
X0306
4
2015-06-30
0
0001454789
CATABASIS PHARMACEUTICALS INC
CATB
0001644160
SVLSF V, LLC
ONE BOSTON PLACE
201 WASHINGTON STREET SUITE 3900
BOSTON
MA
02108
0
0
1
0
0001644146
SV Life Sciences Fund V (GP), LP
ONE BOSTON PLACE
201 WASHINGTON STREET SUITE 3900
BOSTON
MA
02108
0
0
1
0
0001460732
SV LIFE SCIENCES FUND V LP
ONE BOSTON PLACE
201 WASHINGTON STREET SUITE 3900
BOSTON
MA
02108
0
0
1
0
0001482194
SV Life Sciences Fund V Strategic Partners, L.P.
ONE BOSTON PLACE
201 WASHINGTON STREET SUITE 3900
BOSTON
MA
02108
0
0
1
0
Common Stock
2015-06-30
4
C
0
1651223
A
1651223
I
See Footnotes
Common Stock
2015-06-30
4
C
0
34893
A
34893
I
See Footnotes
Common Stock
2015-06-30
4
C
0
764309
A
2415532
I
See Footnotes
Common Stock
2015-06-30
4
C
0
16152
A
51045
I
See Footnotes
Common Stock
2015-06-30
4
P
0
382996
12
A
2798528
I
See Footnotes
Common Stock
2015-06-30
4
P
0
8094
12
A
59139
I
See Footnotes
Series A Preferred Stock
2015-06-30
4
C
0
21218253
0
D
Common Stock
1651223
0
I
See Footnotes
Series A Preferred Stock
2015-06-30
4
C
0
448414
0
D
Common Stock
34893
0
I
See Footnotes
Series B Preferred Stock
2015-06-30
4
C
0
9821385
0
D
Common Stock
764309
0
I
See Footnotes
Series B Preferred Stock
2015-06-30
4
C
0
207558
0
D
Common Stock
16152
0
I
See Footnotes
The Series A and Series B Preferred Stock converted into Common Stock on a 1-for-12.85 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A and B Preferred Stock were convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
These shares are owned directly by SV Life Sciences Fund V, L.P. ("SVLS V LP"). SV Life Sciences Fund V (GP), LP ("SVLS V GP") is the general partner of SVLS V LP. The general partner of SVLS V GP is SVLSF V, LLC. The members of the investment committee of SVLSF V, LLC are Kate Bingham, James Garvey, Eugene D. Hill, III, David Milne and Michael Ross. SVLS V GP, SVLSF V, LLC and each of the individuals comprising the SVLSF V, LLC investment committee may be deemed to share voting, dispositive and investment power over the shares held of record by SVLS V LP and SVLS V SPP. Each of SVLS V GP, SVLSF V, LLC and the individual members of the SVLSF V, LLC investment committee disclaim beneficial ownership of the shares owned directly by SVLS V LP except to the extent of any pecuniary interest therein.
These shares are owned directly by SV Life Sciences Fund V Strategic Partners, L.P. ("SVLS V SPP"). SV Life Sciences Fund V (GP), LP ("SVLS V GP") is the general partner of SVLS V SPP. The general partner of SVLS V GP is SVLSF V, LLC. The members of the investment committee of SVLSF V, LLC are Kate Bingham, James Garvey, Eugene D. Hill, III, David Milne and Michael Ross. SVLS V GP, SVLSF V, LLC and each of the individuals comprising the SVLSF V, LLC investment committee may be deemed to share voting, dispositive and investment power over the shares held of record by SVLS V LP and SVLS V SPP. Each of SVLS V GP, SVLSF V, LLC and the individual members of the SVLSF V, LLC investment committee disclaim beneficial ownership of the shares owned directly by SVLS V SPP except to the extent of any pecuniary interest therein.
SVLS V LP and SVLS V SPP (each a "Fund," or collectively the "Funds") may be deemed to beneficially own the shares held by each other Fund because of certain contractual relationships among the Funds and their affiliates. The Funds disclaim beneficial ownership of shares held by any other Fund except to the extent of any pecuniary interest therein.
By:/s/ Denise Marks, Member of SVLSF V, LLC
2015-06-30
By:/s/ Denise Marks, Member of SVLSF V, LLC, general partner of SV Life Sciences Fund V (GP), L.P.
2015-06-30
By:/s/ Denise Marks, Member of SVLSF V, LLC, general partner of SV Life Sciences Fund V (GP), L.P., general partner of SV Life Sciences Fund V, L.P.
2015-06-30
By:/s/ Denise Marks, Member of SVLSF V, LLC, general partner of SV Life Sciences Fund V (GP), L.P., general partner of SV Life Sciences Fund V Strategic Partners, L.P.
2015-06-30